Literature DB >> 15833929

Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver.

Jonathan M Maher1, Xingguo Cheng, Angela L Slitt, Matthew Z Dieter, Curtis D Klaassen.   

Abstract

The multidrug resistance-associated proteins (Mrp) are ATP-dependent transporters that export a variety of conjugated and unconjugated compounds out of cells. There are nine identified Mrp transporters in humans, with murine orthologs for all except Mrp8. Because nuclear receptors mediate induction of phase I enzymes, Mrp transporter expression might be similarly regulated by these receptors to coordinate metabolism and export of chemicals from liver. To test the hypothesis that Mrp expression may be coordinately regulated with phase I enzyme expression in liver, 15 different compounds were given representing known transcriptionally mediated pathways: aryl hydrocarbon receptor (AhR), pregnane X receptor (PXR), constitutive androstane receptor (CAR), peroxisome proliferator-activated receptor alpha (PPARalpha), and nuclear factor-E2-related factor 2 (Nrf2). Each of these compounds induced expression of their respective target enzyme in liver, demonstrating that the chemical regimens were effective. The AhR ligands [2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polychlorinated biphenyl 126 (PCB126), and beta-naphthoflavone] induced Mrp2, -3, -5, and -6 mRNA expression. The CAR activator 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) induced Mrp2, -3, -4, -6, and -7 mRNA expression. Mrp3 was also induced by two other CAR activators phenobarbital and diallyl sulfide, two PXR ligands, pregnenalone-16alpha-carbonitrile and spironolactone, and the PPARalpha ligands clofibrate, ciprofibrate, and diethylhexylphthalate. The Nrf2 activators (butylated hydroxyanisole, oltipraz, and ethoxyquin) induced Mrp2-6. In conclusion, a variety of mechanisms are suggested for Mrp3 induction, including AhR, CAR, PXR, PPARalpha, and Nrf2, whereas on a whole, a predominant role for AhR and Nrf2 in hepatic induction of the Mrp family was observed. Thus, these specific transcription factors are implicated in regulation of both drug metabolism and efflux transport.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833929     DOI: 10.1124/dmd.105.003798

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  87 in total

1.  A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62.

Authors:  Alexandria Lau; Xiao-Jun Wang; Fei Zhao; Nicole F Villeneuve; Tongde Wu; Tao Jiang; Zheng Sun; Eileen White; Donna D Zhang
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

2.  Renal efflux transporter expression in pregnant mice with Type I diabetes.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  Toxicol Lett       Date:  2012-04-17       Impact factor: 4.372

3.  Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice.

Authors:  Jun Ozeki; Shigeyuki Uno; Michitaka Ogura; Mihwa Choi; Tetsuyo Maeda; Kenichi Sakurai; Sadanori Matsuo; Sadao Amano; Daniel W Nebert; Makoto Makishima
Journal:  Toxicology       Date:  2010-11-21       Impact factor: 4.221

4.  Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses.

Authors:  Qiang Zhang; Jingbo Pi; Courtney G Woods; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-14       Impact factor: 4.219

5.  Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.

Authors:  Deep Kwatra; Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Varun Khurana; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Metabol Drug Interact       Date:  2014

6.  Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Kylee E Eblin; Jay A Gandolfi; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-07       Impact factor: 4.219

Review 7.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

8.  The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.

Authors:  Jennifer C Schroeder; Brett C Dinatale; Iain A Murray; Colin A Flaveny; Qiang Liu; Elizabeth M Laurenzana; Jyh Ming Lin; Stephen C Strom; Curtis J Omiecinski; Shantu Amin; Gary H Perdew
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

9.  PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

Authors:  Vijay R More; Christopher R Campos; Rebecca A Evans; Keith D Oliver; Gary Ny Chan; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

10.  Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy.

Authors:  Lauren M Aleksunes; Ronnie L Yeager; Xia Wen; Julia Yue Cui; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.